Why Is Grip Strength So Important? What It Reveals About Your Health

TL;DR

• It is a muscle test, not a heart test. Grip strength measures the force your hand can generate. It reflects muscle, nervous-system function, activity levels and underlying illness all at once, which is why it tracks so many different outcomes.
• Change matters more than level. In a 2026 UK Biobank analysis of 41,538 adults measured twice, about 9.7 years apart, declining grip strength was linked to a 12% higher hazard of cardiovascular disease. The association with a single low baseline reading disappeared entirely once frailty was accounted for.
• The brain findings are real but modest. Two 2026 meta-analyses linked lower grip strength to incident depression (pooled odds ratio 1.42) and to cognitive decline (around 19% lower risk with higher strength). Neither makes a dynamometer a screening test.
• Both hands carry information. Across nine cohorts and 900,253 people, a difference in strength between hands was associated with a 12% higher hazard of death from any cause, and 39% when combined with low grip strength overall.
• 27 kg and 16 kg are clinical thresholds, not targets. European sarcopenia guidance uses those cut-offs to flag low muscle strength for further assessment. They are not age-specific averages or fitness goals.
• Hand training is not the lesson. Whole-body strength work has clear functional benefits. Nothing in this research shows that strengthening your hands alone prevents heart disease, dementia or early death.

Why Has Grip Strength Become Such an Important Health Measure?

A handgrip test takes seconds. Someone squeezes a handheld dynamometer as hard as they can, and the device records the force produced. It is an unusually cheap measurement for something now linked to a remarkably wide span of health outcomes, from heart attacks to dementia.

Part of the appeal is practical. The test is inexpensive, repeatable under standard conditions, and open to people who could never complete a treadmill test. Large cohort studies have therefore collected grip readings on hundreds of thousands of people, which has made it one of the most heavily analysed single measurements in population health. Its meaning is also easily overstated. Grip strength does not measure the health of your heart, the condition of your brain or the speed at which you are ageing. It measures the capacity to generate force through the hand, which is shaped by activity, nutrition, neurological function, illness and age all at once.

What has changed recently is the question being asked. Studies published in 2025 and 2026 have moved past comparing strong people with weak people at a single moment, and started asking what happens when strength falls, whether the link holds in people with inflammation, and whether the difference between your two hands adds anything. The picture that emerges is more useful than the familiar claim that a strong handshake predicts a long life.

What Happens When Your Grip Strength Declines?

The most important recent study on this appeared in BMC Public Health in February 2026. Researchers used UK Biobank participants who had grip strength measured twice: once at recruitment and again at an imaging visit, with a median gap of 9.7 years between the two. The analysis of change covered 41,538 people, who were then followed for a median of 3.8 years, during which 4,945 cardiovascular events occurred.

Participants whose standardised grip strength fell between the two visits had a 12% higher adjusted hazard of cardiovascular disease than the reference group (HR 1.12; 95% CI 1.04–1.21). Those whose strength stayed consistently low had a 14% higher hazard (HR 1.14; 95% CI 1.02–1.28). When the researchers instead classified people by whether they had crossed into a weakness category, moving from normal strength to weakness carried a 19% higher hazard (HR 1.19; 95% CI 1.09–1.30). These are relative differences between groups, not percentage-point increases in any individual's chance of developing heart disease.

The frailty analysis is what makes the study interesting. Low grip strength is itself one component of standard frailty definitions, so the authors re-ran everything with frailty added to the model. The single baseline reading then lost its association with cardiovascular disease completely (HR 0.99; 95% CI 0.94–1.04). The decline group held up (HR 1.13; 95% CI 1.05–1.22), and so did the move from normal strength into weakness. People who went the other way, from weakness back to normal, had a 12% lower hazard (HR 0.88; 95% CI 0.80–0.98).

That pattern is the reason to pay attention to trajectory rather than to a number on a single day. It remains an observational study, and the direction of causation is unsettled: illness, inactivity or early cardiovascular damage could all drive strength downwards rather than the reverse. The authors also excluded 13,284 people whose cardiovascular events fell between the two visits, in order to guard against reverse causation, and they note this may have made the true association look weaker rather than stronger. The cohort was aged 37 to 73 at recruitment, and they caution against extending the findings beyond roughly 40 to 70.

Does Grip Strength Reveal Anything About Brain Health?

Two substantial meta-analyses published in 2026 extended the measurement into mental and cognitive health. The first, in the Journal of Psychiatric Research, pooled twelve unique prospective cohorts covering 497,336 people and 3.4 million person-years. People with lower grip strength had higher odds of developing depressive symptoms or depression, with a pooled odds ratio of 1.42 (95% CI 1.14–1.78). The authors describe this as statistically significant but clinically small, and they searched the literature only to February 2025, so the underlying cohorts are not themselves new.

The second, in Neuroscience & Biobehavioral Reviews, brought together 60 studies, 380,960 participants and 37 prospective cohorts of adults aged 45 and over. Higher baseline grip strength was associated with a lower risk of incident cognitive decline (RR 0.812; 95% CI 0.766–0.860), and maintaining or increasing grip strength showed a similar result (RR 0.809; 95% CI 0.738–0.886). Both work out at roughly 19% lower relative risk. Baseline strength did not reliably predict the rate at which cognition changed over time, which is a different question from whether impairment develops at all.

Neither review shows that stronger hands protect the brain, and the authors of both are careful about quality: 80% of the studies in the cognition review were rated only moderate on the QUIPS checklist. The cognition reviewers do call grip strength a clinically meaningful biomarker, so this is not a case of researchers dismissing their own finding. The honest reading is that grip strength appears to sit alongside depression and cognitive decline as a marker of general physical and neurological condition, and that a marker associated with this many different outcomes is probably reflecting broad vulnerability rather than pointing at one disease process.

Why Might Muscle Strength Reflect More Than Muscle Size?

Grip strength depends on the muscles of the hand and forearm, but force output is not set by muscle quantity alone. The nervous system has to recruit and coordinate motor units, which are groups of muscle fibres controlled by individual motor neurons. Ageing affects muscle and nerve at different rates, so quantity and strength can diverge: neuromuscular function and muscle quality change how effectively existing tissue produces force. That is why measuring muscle mass alone gives an incomplete account of physical function.

It also offers a plausible route for the wider health associations, since chronic illness, inactivity, neurological impairment and poor nutrition can all depress strength through different pathways. It would be misleading, though, to say that grip strength principally measures nerve supply rather than muscle. Both contribute, and a dynamometer cannot separate them. Nor do these mechanisms establish that weak grip causes cardiovascular or cognitive disease. In some cases a falling grip is an early consequence of the same processes that later produce other symptoms, which is exactly why training the hands may not change the outcomes the measurement predicts.

What Does Inflammation Have to Do With Grip Strength?

A study published in the Journal of Cachexia, Sarcopenia and Muscle in April 2026 asked whether grip strength still tracked mortality in people with raised systemic inflammation. The researchers analysed 20,941 participants from the Survey of Health, Ageing and Retirement in Europe, mean age 68, grouped by C-reactive protein, a blood marker that rises during infection and inflammatory disease. Over roughly five years of follow-up, mortality was 14.7% among those with CRP above 3 mg/L, 22.5% above 10 mg/L and 30.2% above 25 mg/L.

The relationship was curvilinear, with a significant interaction between CRP and grip strength (p = 0.0131). Taking median grip strength as the reference, which was 30 kg in the lowest CRP group and 28 kg in the other two, participants at the tenth percentile of strength had adjusted hazard ratios of 1.84 (95% CI 1.59–2.14), 1.69 (95% CI 1.33–2.15) and 1.92 (95% CI 1.17–3.17) across the three groups. At the ninetieth percentile the direction reversed: 0.57, 0.50 and 0.38 respectively. The widest of these intervals, in the highest-CRP group, reflects how few people sit in it.

These are comparisons within inflammatory groups, not evidence that strength neutralises inflammation, and the groups overlap by construction, since anyone above 25 mg/L also exceeds the lower thresholds. CRP is also not a disease. It rises for very different reasons, and people with high readings differ in illness burden, medication and activity, all of which affect both strength and survival. What the study supports is grip strength as a supplementary indicator in older adults, not a treatment strategy and certainly not hand exercises as a way to lower inflammation.

Does It Matter If One Hand Is Stronger Than the Other?

A 2026 systematic review and meta-analysis in Archives of Gerontology and Geriatrics examined grip-strength asymmetry, meaning the difference in force between the two hands. Searching to January 2026, it pooled nine cohort studies covering 900,253 participants. Asymmetry was associated with a 12% higher hazard of death from any cause (HR 1.12; 95% CI 1.07–1.17) and a 29% higher hazard of cardiovascular death, on a much wider interval (HR 1.29; 95% CI 1.03–1.62). Where asymmetry and low overall grip strength occurred together, the hazard of all-cause death was 39% higher (HR 1.39; 95% CI 1.17–1.65).

Comparing both hands may therefore add something to measuring maximum force alone. But a degree of asymmetry is normal: hand dominance, occupation, sport, arthritis and old injuries all produce differences, and the included studies defined asymmetry in different ways, so the pooled figure cannot be converted into a threshold at which one stronger hand becomes a medical concern. The review's authors also go further than the data warrants in describing asymmetry as outperforming single-hand assessment. What the meta-analysis shows is an association, measured in cohorts that were never designed to test whether evening out the two hands changes anything.

Is Grip Strength Better Than Other Simple Fitness Tests?

Grip strength is convenient, but it is not the only quick measure of muscular function. A 2025 study in the Brazilian Journal of Physical Therapy compared handgrip strength with the five-repetition chair-stand test in 43,605 community-dwelling adults aged 50 and over, following them for a mean of 7.3 years, during which 4,154 died. The chair-stand test records how long it takes to rise from a seated position and sit back down five times, and depends far more on lower-body strength and functional movement.

Both predicted mortality, and grip strength predicted it more strongly. Against a median of 33 kg, people at the tenth percentile of grip strength (21 kg) had a hazard ratio of 1.62 (95% CI 1.50–1.75), while those at the ninetieth percentile (51 kg) sat at 0.58 (95% CI 0.52–0.64). For the chair-stand test, against a median of 11 seconds, the ninetieth percentile (18 seconds) gave a hazard ratio of 1.18 (95% CI 1.14–1.22). Chair-stand performance was most strongly associated with mortality in women.

One caveat worth holding on to: this study and the inflammation study above both draw on the same European survey, so they are not independent confirmations of each other. And a better statistical association does not make grip strength the better test for every purpose. Someone with strong hands may still struggle to rise from a chair or hold their balance, while a person with hand arthritis may record a low grip despite good lower-body function. The most informative assessment combines measures rather than hunting for one perfect number.

What Is a Good Grip Strength for Your Age?

There is no single healthy grip-strength figure that applies to everyone. Age, sex, body size, hand dominance, equipment and arm position all change the result, which is why published "averages by age" should be treated with caution. For clinical purposes, the revised European Working Group on Sarcopenia in Older People consensus, known as EWGSOP2, sets thresholds for identifying low muscle strength.

Under the EWGSOP2 pathway, low muscle strength raises the suspicion of sarcopenia. Reduced muscle quantity or quality is then used to confirm it, and physical-performance measures establish severity. These are screening cut-offs, not ideal targets and not age-specific norms, and a reading above the threshold is no guarantee of good muscular health. What they do is give a weak reading a defined clinical context, so that a clinician can decide whether to look further at muscle function, nutrition, activity or underlying illness.

If you are tracking your own strength, the protocol matters more than the number: use the same dynamometer, arm position and number of attempts each time, or you will mistake an equipment change for physiological decline. Sudden weakness, especially on one side of the body or alongside facial changes or difficulty speaking, needs urgent medical assessment rather than a grip test.

Does Grip Strength Really Predict Longevity?

This is where association and useful prediction part company. The large 2018 UK Biobank analysis of 502,293 participants, followed for a mean of 7.1 years with 13,322 deaths, found that adding grip strength to a conventional risk model did improve its ability to separate those who died from those who survived. The improvement in the model's C-index was 0.013 for all-cause mortality, 0.012 for cardiovascular mortality and 0.009 for incident cardiovascular disease. The C-index measures how well a model discriminates between people with different outcomes, and changes that small show that a strongly associated variable can still add very little to a model that already includes age, blood pressure and the rest.

A 2021 umbrella review by Soysal and colleagues supplies the other qualification. Across eight systematic reviews and eleven outcomes, no association reached the strictest classification of convincing evidence. Three reached the next class, highly suggestive: all-cause mortality in the general population (RR 0.72; 95% CI 0.67–0.78, from 34 studies and 1,855,817 people), cardiovascular death in mixed populations (RR 0.84; 95% CI 0.78–0.91) and incident disability (RR 0.76; 95% CI 0.66–0.87). The reviewers described the mortality result as a minor reduction in risk, and noted that every meta-analysis they examined scored low or critically low on the AMSTAR 2 quality tool.

These older papers remain worth citing because they test the credibility and clinical value of grip-strength prediction rather than adding another association to the pile. The newer research strengthens the case that grip strength contains health information. It does not settle whether measuring it routinely improves clinical decisions, and a dynamometer cannot substitute for blood pressure, cholesterol or diabetes assessment.

Can Improving Grip Strength Improve Your Health?

Grip strength does respond to training. Weights, pulling, carrying and gripping work all strengthen the hands and forearms, and broader resistance training develops the major muscle groups. But the studies linking grip strength to disease and death do not show that isolated grip training prevents those outcomes, and there is a real difference between improving a measurement and changing the things that made the measurement informative.

A person can become better at squeezing a dynamometer through local adaptation and practice alone, without their cardiovascular fitness, metabolic health, lower-body strength or neurological function moving with it. This is why the practical emphasis belongs on whole-body function. UK physical activity guidance recommends strengthening activities involving the major muscle groups on at least two days a week, alongside regular aerobic activity. For older adults in particular, exercises that protect the ability to rise from a chair, climb stairs and carry shopping matter more than any handgrip figure. Hand-specific work still has a place when grip itself limits daily tasks, such as opening jars; judge it by whether those tasks get easier, not by promises about lifespan.

What This Actually Means

Grip strength matters because it gives a simple, repeatable measure of muscular function, and because recent research suggests that both its level and its direction of travel carry information about wider health. The 2026 cardiovascular study is the one that shifts the emphasis: a single low reading lost its association once frailty was accounted for, while a falling reading did not. The depression and cognition meta-analyses extend the association into brain health, and the inflammation and asymmetry work suggests the measurement holds information that absolute force alone does not.

None of this turns grip strength into a general health test. A low result can reflect natural variation, injury, inactivity, neurological impairment or an undiagnosed illness, so its meaning depends on the person and the circumstances. The useful question is not whether you can hit an impressive score, but whether your muscular function is adequate for your life, whether it is changing, and whether any decline has an explanation. Keep training strength across the whole body, stay active, and take an unexplained loss of strength seriously enough to mention it to a doctor. Treating the grip reading itself as the target gets the logic backwards.

Frequently Asked Questions

Why is grip strength linked to heart disease?

Grip strength reflects muscular and general physical condition, which overlaps heavily with cardiovascular risk. A 2026 UK Biobank study linked declining grip strength to subsequent cardiovascular disease, but a single low reading lost its association once frailty was taken into account, and no study has shown that weakness directly causes heart disease.

What is a normal grip strength for a 40-, 50- or 60-year-old?

Normal values vary by age, sex, body size, equipment and technique, so published age charts are rough at best. European sarcopenia guidance uses below 27 kg for men and below 16 kg for women to flag low muscle strength, but those are clinical screening thresholds rather than age-specific averages or targets to train towards.

Does grip strength predict dementia?

A 2026 meta-analysis of 60 studies found higher grip strength associated with roughly 19% lower risk of incident cognitive decline. It did not reliably predict how fast cognition changed over time, and it cannot diagnose or forecast dementia in any individual.

Can weak grip strength indicate depression?

Lower grip strength was associated with later depressive outcomes in a 2026 meta-analysis of twelve cohorts, with a pooled odds ratio of 1.42. The authors call the association statistically significant but clinically small, which is a long way from a useful individual test.

Will using a hand gripper help me live longer?

Hand grippers strengthen the muscles they load, and that can help if your grip limits everyday tasks. There is no evidence that isolated hand exercise extends life, and whole-body resistance training carries the broader functional benefits.

The Bottom Line

Grip strength is important not because the hands hold some secret to longevity, but because the force they produce reflects several dimensions of physical health at once. Research published in 2025 and 2026 has tied declining strength to cardiovascular disease, and lower strength to depression, cognitive decline and mortality, with the difference between your two hands possibly adding more.

That makes it a measurement worth taking seriously, particularly for tracking muscular function over time. It does not make it a longevity intervention. An association with living longer is not evidence that raising the number extends your life, and the honest practical message is simpler: preserve strength across the whole body throughout adulthood, look into any meaningful unexplained decline, and treat a handgrip reading as one small part of a much larger picture.

This article is for general information and is not medical advice. If you are concerned about weakness, unexplained loss of strength, or your cardiovascular risk, speak to your GP.

Sources

• Chai L, Zhang Y, Zhang K, Wang W, Zhang D, Fan J. Association of changes in grip strength with risk of incident cardiovascular disease in middle aged and older adults from the UK biobank. BMC Public Health. 2026 Feb 4;26:817. https://pubmed.ncbi.nlm.nih.gov/41639845/
• de Oliveira J, et al. Association between handgrip strength and incident depression: a meta-analysis of prospective cohort studies. Journal of Psychiatric Research. 2026 May. https://pubmed.ncbi.nlm.nih.gov/41690152/
• Younis M, Vints WAJ, Bautmans I, et al. Handgrip performance as a predictor of incident cognitive decline in older adults: a systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews. 2026 Sep. https://pubmed.ncbi.nlm.nih.gov/42269958/
• Tur-Boned A, et al. Dose-response association between handgrip strength and all-cause mortality across different levels of systemic inflammation. Journal of Cachexia, Sarcopenia and Muscle. 2026 Apr. https://pubmed.ncbi.nlm.nih.gov/41895225/
• Ran M, Yu Y, Chen L, Zhou X. Handgrip strength asymmetry is associated with mortality risk: systematic review and meta-analysis. Archives of Gerontology and Geriatrics. 2026 Jul. https://pubmed.ncbi.nlm.nih.gov/41955643/
• Núñez-Cortés R, et al. Five-repetition chair-stand test vs. handgrip strength: which better predicts mortality risk? A follow-up study in 43,605 middle-aged and older adults. Brazilian Journal of Physical Therapy. 2025 Nov-Dec. https://pubmed.ncbi.nlm.nih.gov/40992236/
• Soysal P, Hurst C, Demurtas J, et al. Handgrip strength and health outcomes: umbrella review of systematic reviews with meta-analyses of observational studies. Journal of Sport and Health Science. 2021;10:290–295. https://pubmed.ncbi.nlm.nih.gov/32565244/
• Celis-Morales CA, Welsh P, Lyall DM, et al. Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality. BMJ. 2018;361:k1651. https://doi.org/10.1136/bmj.k1651
• Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing. 2019;48:16–31. https://doi.org/10.1093/ageing/afy169
• UK Chief Medical Officers' Physical Activity Guidelines. Department of Health and Social Care, 2019. https://www.gov.uk/government/publications/physical-activity-guidelines-uk-chief-medical-officers-report